Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Hardman & Co Research: Oakley Capital Investments (OCI) - initiation of coverage: 'When it rains gold, put out the bucket'
Hardman & Co Research: Oakley Capital Investments (OCI) - initiation of coverage: 'When it rains gold, put out the bucket'
Hardman & Co Research: Oakley Capital Investments (OCI) - initiation of coverage: 'When it rains gold, put out the bucket'
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Hardman & Co Research: Primary Health Properties (PHP): Strong set of results, confirming ongoing rent rises
Hardman & Co Research: Primary Health Properties (PHP): Strong set of results, confirming ongoing rent rises
Hardman & Co Research: Primary Health Properties (PHP): Strong set of results, confirming ongoing rent rises
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Hardman & Co Research: Q&A with Mark Thomas on Non-Standard Finance (NSF): FY'19 solid; outlook - broad range of outcomes
Hardman & Co Research: Q&A with Mark Thomas on Non-Standard Finance (NSF): FY'19 solid; outlook - broad range of outcomes
Hardman & Co Research: Q&A with Mark Thomas on Non-Standard Finance (NSF): FY'19 solid; outlook - broad range of outcomes
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Hardman & Co Research: City of London Investment Group (CLIG): Market recovery boosts FUM
Hardman & Co Research: City of London Investment Group (CLIG): Market recovery boosts FUM
Hardman & Co Research: City of London Investment Group (CLIG): Market recovery boosts FUM
Hardman & Co Research: Non-Standard Finance Plc (NSF): FY'19 solid; outlook - broad range of outcomes
Hardman & Co Research: Non-Standard Finance Plc (NSF): FY'19 solid; outlook - broad range of outcomes
Hardman & Co Research: Non-Standard Finance Plc (NSF): FY'19 solid; outlook - broad range of outcomes
Hardman & Co Research: City of London Investment Group (CLIG): Karpus transaction looks a winner
Hardman & Co Research: City of London Investment Group (CLIG): Karpus transaction looks a winner
Hardman & Co Research: City of London Investment Group (CLIG): Karpus transaction looks a winner
Hardman & Co Research: Arix Bioscience (ARIX): 1Q'20 portfolio update
Hardman & Co Research: Arix Bioscience (ARIX): 1Q'20 portfolio update
Hardman & Co Research: Arix Bioscience (ARIX): 1Q'20 portfolio update
Hardman & Co Research: Arix Bioscience (ARIX): Resetting the stage
Hardman & Co Research: Arix Bioscience (ARIX): Resetting the stage
Hardman & Co Research: Arix Bioscience (ARIX): Resetting the stage
Hardman & Co Research: City of London Investment Group (CLIG): Handling challenging markets well
Hardman & Co Research: City of London Investment Group (CLIG): Handling challenging markets well
Hardman & Co Research: City of London Investment Group (CLIG): Handling challenging markets well
Hardman & Co Research: Arix Bioscience (ARIX): Fiscal 2019 - moving with the times
Hardman & Co Research: Arix Bioscience (ARIX): Fiscal 2019 - moving with the times
Hardman & Co Research: Arix Bioscience (ARIX): Fiscal 2019 - moving with the times
Hardman & Co Research: Q&A with Mike Foster on Primary Health Properties (PHP): Final results show accelerating rental growth
Hardman & Co Research: Q&A with Mike Foster on Primary Health Properties (PHP): Final results show accelerating rental growth
Hardman & Co Research: Q&A with Mike Foster on Primary Health Properties (PHP): Final results show accelerating rental growth
Edison Investment Research Limited: Edison issues outlook on Primary Health Properties (PHP)
Edison Investment Research Limited: Edison issues outlook on Primary Health Properties (PHP)
Edison Investment Research Limited: Edison issues outlook on Primary Health Properties (PHP)
Hardman & Co Research:  Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)
Hardman & Co Research: Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)
Hardman & Co Research: Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)